drug manufacturing

  • Major Drug Bust: Maharashtra Police Seize Rs 100 Crore Worth MD Drugs and Equipment in Rajasthan Factory

    Major Drug Bust: Maharashtra Police Seize Rs 100 Crore Worth MD Drugs and Equipment in Rajasthan Factory

    Dec 16, 2025 12:40 am CST

    Maharashtra police's Anti-Narcotics Cell has uncovered an illegal MD drug manufacturing operation in Rajasthan's Jhunjhunu district, seizing contraband, chemicals, and equipment valued at approximately Rs 100 crore. The operation, which began with intelligence-led searches in Thane, has resulted in multiple arrests across two states as authorities dismantled this significant drug manufacturing network.

  • Maharashtra Drug Bust: Shiv Sena Leader Under Investigation After MD Drug Factory Discovered in Satara

    Maharashtra Drug Bust: Shiv Sena Leader Under Investigation After MD Drug Factory Discovered in Satara

    Dec 14, 2025 12:20 pm CST

    Mumbai crime branch busted an MD drug manufacturing unit in Maharashtra's Satara, seizing over 10kg of drugs and arresting three individuals. Investigations revealed potential connections to a Shiv Sena leader from Eknath Shinde's faction, as food for workers was allegedly supplied from a hotel owned by the leader. State Congress President has demanded answers regarding possible political connections to the illegal operation.

  • Trump

    Trump's 100% Pharmaceutical Tariffs: Global Impact on Countries and Companies

    Sep 26, 2025 10:59 pm CST

    President Trump's announcement of 100% tariffs on imported branded pharmaceuticals has sent shockwaves through the global drug industry. This policy, set to take effect in five days unless companies begin constructing US manufacturing facilities, threatens international pharmaceutical trade worth $252 billion annually. While the European Union claims protection through an existing trade agreement, countries like Switzerland and Denmark face significant risks. Pharmaceutical giants have already pledged $300 million in US investments as companies scramble to adapt to this protectionist measure that exempts generic medications but targets patented drugs.